3,420.00
-15(-0.44%)
Currency In JPY
Address
1-1, Ichigaya-Honmura cho
Tokyo, 162-0845
Japan
Phone
81 3 3358 7211
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1522
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Hitoshi Mizuno | Managing Executive Officer & GM of Medical Device Product Development | 0 | N/A |
| Junichi Makino | Executive Officer Deputy Head of Pharmaceutical Sales Division | 0 | N/A |
| Junichi Sakaki | Senior Executive Managing Officer & Representative Director | 0 | 1960 |
| Motoi Mitsuishi | Senior Executive Managing Officer & Representative Director | 0 | 1963 |
| Kenji Miyajima | Executive Officer & Head of Pharmaceutical Business Division | 0 | 1967 |
| Masaaki Yokosuka | Executive Officer and Legal & Compliance Manager | 0 | N/A |
| Naoyuki Mochida | President & Chairperson | 0 | 1958 |
| Taiji Hayano | GM of Pharmaceutical Development Division & Managing Executive Officer | 0 | N/A |
| Tomokazu Matsusue | Managing Executive Officer & Head of Business Development Division | 0 | N/A |
| Yutaka Kawakami | Executive Managing Officer Executive Director | 0 | 1959 |
Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.
